177 related articles for article (PubMed ID: 35714620)
1. Standard Fixed Enoxaparin Dosing for Venous Thromboembolism Prophylaxis Leads to Low Peak Anti-Factor Xa Levels in Both Head and Neck and Breast Free Flap Patients.
Ambani SW; Bengur FB; Varelas LJ; Nguyen VT; Cruz C; Acarturk TO; Manders EK; Kubik MW; Sridharan S; Gimbel ML; Solari MG
J Reconstr Microsurg; 2022 Nov; 38(9):749-756. PubMed ID: 35714620
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of weight-based enoxaparin dosing for venous thromboembolism prophylaxis in trauma patients: A systematic review and meta-analysis.
Ebeid A; Cole E; Stallwood-Hall C
J Trauma Acute Care Surg; 2022 Aug; 93(2):e71-e79. PubMed ID: 35583986
[TBL] [Abstract][Full Text] [Related]
3. Enoxaparin 40 mg per Day Is Inadequate for Venous Thromboembolism Prophylaxis After Thoracic Surgical Procedure.
Pannucci CJ; Fleming KI; Holoyda K; Moulton L; Prazak AM; Varghese TK
Ann Thorac Surg; 2018 Aug; 106(2):404-411. PubMed ID: 29626461
[TBL] [Abstract][Full Text] [Related]
4. Low Anti-Factor Xa Level Predicts 90-Day Symptomatic Venous Thromboembolism in Surgical Patients Receiving Enoxaparin Prophylaxis: A Pooled Analysis of Eight Clinical Trials.
Pannucci CJ; Fleming KI; Varghese TK; Stringham J; Huang LC; Pickron TB; Prazak AM; Bertolaccini C; Momeni A
Ann Surg; 2022 Dec; 276(6):e682-e690. PubMed ID: 33086312
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Anti-Factor Xa Levels of Patients Undergoing Colorectal Surgery Given Once-Daily Enoxaparin Prophylaxis: A Clinical Study Examining Enoxaparin Pharmacokinetics.
Pannucci CJ; Fleming KI; Bertolaccini CB; Prazak AM; Huang LC; Pickron TB
JAMA Surg; 2019 Aug; 154(8):697-704. PubMed ID: 31116389
[TBL] [Abstract][Full Text] [Related]
6. Anti-Factor Xa Monitoring of Enoxaparin Thromboembolism Prophylaxis in Emergency General Surgery Patients.
Pokrzywa CJ; Biesboer EA; Figueroa J; Al Tannir AH; de Moya M; Morris RS; Murphy PB
J Am Coll Surg; 2023 Aug; 237(2):195-203. PubMed ID: 37039364
[TBL] [Abstract][Full Text] [Related]
7. Enoxaparin Thromboprophylaxis Dosing and Anti-Factor Xa Levels in Low-Weight Patients.
Yam L; Bahjri K; Geslani V; Cotton A; Hong L
Pharmacotherapy; 2019 Jul; 39(7):749-755. PubMed ID: 31112313
[TBL] [Abstract][Full Text] [Related]
8. Anti-Factor Xa Levels in Low-weight Surgical Patients Receiving Enoxaparin for Venous Thromboembolism Prophylaxis: A Prospective Cohort Study.
Hakeam HA; Al Duhailib Z; Alsemari M; Alwaibah RM; Al Shannan MF; Shalhoub M
Clin Appl Thromb Hemost; 2020; 26():1076029620931194. PubMed ID: 32559127
[TBL] [Abstract][Full Text] [Related]
9. Underdosing of Prophylactic Enoxaparin Is Common in Orthopaedic Trauma and Predicts 90-Day Venous Thromboembolism.
Jones DL; Jones WA; Fleming KI; Higgins TF; Rothberg DL; Zhang Y; Pannucci CJ
J Orthop Trauma; 2019 Nov; 33(11):570-576. PubMed ID: 31634287
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism in burns patients: Are we underestimating the risk and underdosing our prophylaxis?
Lu P; Harms KA; Paul E; Bortz H; Lo C; Cleland H
J Plast Reconstr Aesthet Surg; 2021 Aug; 74(8):1814-1823. PubMed ID: 33414092
[TBL] [Abstract][Full Text] [Related]
11. Anti-factor Xa level monitoring of low-molecular-weight heparin for prevention of venous thromboembolism in critically ill patients (AXaLPE): protocol of a randomised, open-label controlled clinical trial.
Wang C; Ning YC; Song LP; Li PJ; Wang FH; Ding MX; Jiang L; Wang M; Pei QQ; Hu SM; Wang H
BMJ Open; 2023 Oct; 13(10):e069742. PubMed ID: 37880168
[TBL] [Abstract][Full Text] [Related]
12. Utility of anti-factor Xa monitoring in surgical patients receiving prophylactic doses of enoxaparin for venous thromboembolism prophylaxis.
Pannucci CJ; Prazak AM; Scheefer M
Am J Surg; 2017 Jun; 213(6):1143-1152. PubMed ID: 27692434
[TBL] [Abstract][Full Text] [Related]
13. Assessment of empiric body mass index-based thromboprophylactic dosing of enoxaparin after bariatric surgery: evidence for dosage adjustment using anti-factor Xa in high-risk patients.
Karas LA; Nor Hanipah Z; Cetin D; Schauer PR; Brethauer SA; Daigle CR; Aminian A
Surg Obes Relat Dis; 2021 Jan; 17(1):153-160. PubMed ID: 33046419
[TBL] [Abstract][Full Text] [Related]
14. Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients.
Singer GA; Riggi G; Karcutskie CA; Vaghaiwalla TM; Lieberman HM; Ginzburg E; Namias N; Lineen EB
J Trauma Acute Care Surg; 2016 Dec; 81(6):1101-1108. PubMed ID: 27488490
[TBL] [Abstract][Full Text] [Related]
15. Assessment of BMI and Venous Thromboembolism Rates in Patients on Standard Chemoprophylaxis Regimens After Undergoing Free Tissue Transfer to the Head and Neck.
Saadoun R; Bengur FB; Moroni EA; Surucu Y; Veit JA; Khan NI; Daniels K; Rothenberger SD; Kubik M; Solari MG; Sridharan S
JAMA Otolaryngol Head Neck Surg; 2022 Nov; 148(11):1051-1058. PubMed ID: 36201206
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Anti-factor Xa Levels in Female and Male Patients with Obesity After Enoxaparin Application for Thromboprophylaxis.
Wagner J; Wruck H; Lautenbach A; von Kroge P; Wolter S; Mann O; Izbicki J; Duprée A
Obes Surg; 2022 Mar; 32(3):861-867. PubMed ID: 34988894
[TBL] [Abstract][Full Text] [Related]
17. Are We Missing Treatment Standards for Thromboprophylaxis of the Obese and Super-Obese Patient Population? A Prospective Systematic Cohort Study.
Stier C; Koschker AC; Stier R; Sosnierz A; Chiappetta S
Obes Surg; 2020 May; 30(5):1704-1711. PubMed ID: 31974866
[TBL] [Abstract][Full Text] [Related]
18. Increased Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in General Trauma Patients.
Walker CK; Sandmann EA; Horyna TJ; Gales MA
Ann Pharmacother; 2017 Apr; 51(4):323-331. PubMed ID: 28228055
[TBL] [Abstract][Full Text] [Related]
19. Anti-Factor Xa measurements in acute care surgery patients to examine enoxaparin dose.
Wall V; Fleming KI; Tonna JE; Nunez J; Lonardo N; Shipley RW; Nirula R; Pannucci CJ
Am J Surg; 2018 Aug; 216(2):222-229. PubMed ID: 28736059
[TBL] [Abstract][Full Text] [Related]
20. Weight-Based Compared With Fixed-Dose Enoxaparin Prophylaxis After Cesarean Delivery: A Randomized Controlled Trial.
Bruno AM; Allshouse AA; Campbell HM; Branch DW; Lim MY; Silver RM; Metz TD
Obstet Gynecol; 2022 Oct; 140(4):575-583. PubMed ID: 36075079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
